Abstract
Assessment of in-vitro synergy of fosfomycin with meropenem, colistin, amikacin and tigecycline in whole genome sequenced extended and pan drug resistant Klebsiella pneumonia
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
